Tandem Diabetes Care, Inc.
NASDAQ:TNDM
34.81 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 747.718 | 801.217 | 702.799 | 498.83 | 362.305 | 183.866 | 107.601 | 84.248 | 72.85 | 49.722 | 29.007 | 2.475 | 0 |
| Cost of Revenue
| 380.028 | 388.231 | 326.584 | 238.31 | 168.093 | 94.044 | 63.507 | 60.656 | 46.27 | 34.474 | 22.84 | 3.823 | 0 |
| Gross Profit
| 367.69 | 412.986 | 376.215 | 260.52 | 194.212 | 89.822 | 44.094 | 23.592 | 26.58 | 15.248 | 6.166 | -1.348 | 0 |
| Gross Profit Ratio
| 0.492 | 0.515 | 0.535 | 0.522 | 0.536 | 0.489 | 0.41 | 0.28 | 0.365 | 0.307 | 0.213 | -0.545 | 0 |
| Reseach & Development Expenses
| 169.667 | 139.114 | 92.054 | 63.574 | 45.199 | 29.227 | 20.661 | 18.809 | 16.963 | 15.791 | 11.079 | 9.009 | 8.261 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 86.377 | 82.834 | 78.621 | 75.121 | 43.821 | 22.623 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.5 | 0.7 | 0.068 | 0 |
| SG&A
| 352.503 | 335.681 | 261.508 | 204.903 | 165.735 | 105.226 | 86.377 | 82.834 | 78.621 | 75.121 | 44.521 | 22.691 | 15.951 |
| Other Expenses
| 78.75 | -0.004 | 0 | 0 | -7.882 | -77.929 | -10.081 | -5.411 | -3.404 | -3.789 | 44.521 | 22.691 | 0 |
| Operating Expenses
| 522.17 | 474.795 | 353.562 | 268.477 | 210.934 | 134.453 | 107.038 | 101.643 | 95.584 | 90.912 | 55.6 | 31.7 | 24.212 |
| Operating Income
| -233.23 | -61.809 | 8.808 | -7.957 | -16.722 | -44.631 | -62.944 | -78.051 | -69.004 | -75.664 | -49.434 | -33.048 | -24.212 |
| Operating Income Ratio
| -0.312 | -0.077 | 0.013 | -0.016 | -0.046 | -0.243 | -0.585 | -0.926 | -0.947 | -1.522 | -1.704 | -13.354 | 0 |
| Total Other Income Expenses Net
| -78.75 | -31.043 | 7.093 | -28.325 | -7.882 | -77.929 | -10.081 | -5.411 | -3.404 | -3.789 | -9.002 | 2.556 | -0.77 |
| Income Before Tax
| -220.254 | -92.852 | 15.901 | -36.282 | -24.604 | -122.56 | -73.025 | -83.462 | -72.408 | -79.453 | -63.139 | -33.015 | -25.51 |
| Income Before Tax Ratio
| -0.295 | -0.116 | 0.023 | -0.073 | -0.068 | -0.667 | -0.679 | -0.991 | -0.994 | -1.598 | -2.177 | -13.341 | 0 |
| Income Tax Expense
| 2.357 | 1.742 | 0.335 | -1.9 | 0.149 | 0.051 | 0.008 | -0.015 | 0.01 | 0.071 | 4.71 | 2.525 | 0.542 |
| Net Income
| -222.611 | -94.594 | 15.566 | -34.382 | -24.753 | -122.611 | -73.033 | -83.447 | -72.418 | -79.524 | -63.139 | -33.015 | -25.51 |
| Net Income Ratio
| -0.298 | -0.118 | 0.022 | -0.069 | -0.068 | -0.667 | -0.679 | -0.99 | -0.994 | -1.599 | -2.177 | -13.341 | 0 |
| EPS
| -3.43 | -1.47 | 0.25 | -0.56 | -0.42 | -2.55 | -12.86 | -27.3 | -25.04 | -34.17 | -214.61 | -26.32 | -20.34 |
| EPS Diluted
| -3.43 | -1.47 | 0.24 | -0.56 | -0.42 | -2.55 | -12.86 | -27.3 | -25.04 | -34.17 | -214.61 | -26.32 | -20.34 |
| EBITDA
| -118.224 | -30.77 | 22.653 | -7.957 | -16.722 | -44.631 | -62.944 | -78.051 | -69.004 | -75.664 | -46.261 | -31.014 | -22.922 |
| EBITDA Ratio
| -0.158 | -0.038 | 0.032 | -0.016 | -0.046 | -0.243 | -0.585 | -0.926 | -0.947 | -1.522 | -1.595 | -12.532 | 0 |